| |
| | Botulinum Toxin |
 | | Botulinum toxin type B (Myobloc) was approved by the Food and Drug Administration for symptomatic treatment of patients with cervical dystonia (i.e., spasmodic torticollis) to reduce the severity of abnormal head position and neck associated with cervical dystonia. |
 | | The evidence of botulinum toxin in the treatment of piriformis syndrome is limited to a small, controlled short-term study and a small pilot cross-over study reporting on the impact of botulinum toxin on pain, but not on disability and function (Fishman, et al., 2002; Childers, et al., 2002). |
 | | Botulinum toxin is injected into the external urethral sphincter to treat detrusor sphincter dyssynergia, while intra-detrusal injections of botulinum toxin is employed in treating detrusor overactivity and symptoms of the overactive bladder (OAB). |
| www.aetna.com /cpb/medical/data/100_199/0113.html (10571 words) |
|